Carastock.

The stock of Cara Therapeutics Inc (CARA) has seen a -11.28% decrease in the past week, with a -16.90% drop in the past month, and a -60.67% decrease in the past quarter. The volatility ratio for the week is 10.49%, and the volatility levels for the past 30 days are at 10.66% for CARA.

Carastock. Things To Know About Carastock.

Stock Taking: Pengertian, Manfaat dan Cara Melakukannya. General / By Author / 07/12/2022. Stock Taking adalah sebuah proses dalam manajemen inventory yang bertujuan untuk mengetahui jumlah stok barang yang tersedia pada suatu saat. Artikel ini akan menjelaskan terkait hal tersebut mulai dari manfaat dan cara melakukannya.Cara Therapeutics Inc’s ( CARA) price is currently down 36.91% so far this month. During the month of March, Cara Therapeutics Inc’s stock price has reached a high of $10.39 and a low of $6.11. Over the last year, Cara Therapeutics Inc has hit prices as high as $13.97 and as low as $6.58. Year to date, Cara Therapeutics Inc’s stock is ...The Trend in the Analyst Price Target. CARA's average price target has moved down $22.12 over the prior 42 months. Over the past 45 weeks, CARA's average upside potential has been 426.28%. Date.Oct 23, 2023 · Cara Therapeutics Reports Second Quarter 2023 Financial Results. – 2Q23 total revenue of $6.9M including collaborative revenue of $5.4M from the Company’s share of profit of KORSUVA ® (difelikefalin) injection – – Demand for KORSUVA injection accelerating with 46% increase in vial orders quarter to quarter – – 2024 ESRD PPS ...

Cara Therapeutics Stock Earnings. The value each CARA share was expected to gain vs. the value that each CARA share actually gained. Cara Therapeutics ( CARA) reported Q3 2023 earnings per share (EPS) of -$0.52, meeting estimates of -$0.52 by 0.60%. In the same quarter last year, Cara Therapeutics 's earnings per share (EPS) was -$0.43.Webull offers Cara Therapeutics Inc stock information, including NASDAQ: CARA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CARA stock news, and many more online research tools to help you make informed decisions.Cara Therapeutics Reports Second Quarter 2023 Financial Results. – 2Q23 total revenue of $6.9M including collaborative revenue of $5.4M from the Company’s share of profit of KORSUVA ® (difelikefalin) injection – – Demand for KORSUVA injection accelerating with 46% increase in vial orders quarter to quarter – – 2024 ESRD PPS ...

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $152.77M. -68.8%. Market Cap / Employee. The market cap of a ...

According to the issued ratings of 6 analysts in the last year, the consensus rating for Cara Therapeutics stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 4 buy ratings for CARA. The average twelve-month price prediction for Cara Therapeutics is $15.86 with a high price target of $25.00 and a low price target of $4.00.Cara Therapeutics Inc Follow Share $1.06 After Hours: $1.02 (3.77%) -0.040 Closed: Dec 1, 7:55:45 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Adicet Bio Inc $1.23 ACET4.24% Tilray Brands...Dec 1, 2023 · 6 brokerages have issued 1-year price targets for Cara Therapeutics' stock. Their CARA share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $15.86 in the next twelve months. This suggests a possible upside of 1,396.0% from the stock's current price. Browse Getty Images' premium collection of high-quality, authentic Cara stock photos, royalty-free images, and pictures. Cara stock photos are available in ...Cara Therapeutics Inc (CARA) stock is trading at $5.51 as of 3:36 PM on Tuesday, Mar 21, a gain of $0.21, or 3.96% from the previous closing price of $5.30. The stock has traded between $5.31 and $5.53 so far today. Volume today is below average.

Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...

Cara Therapeutics (CARA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

Cara Therapeutics Inc (CARA) stock has fallen -6.06% while the S&P 500 has risen 0.34% as of 12:40 PM on Tuesday, Nov 7. CARA has fallen -$0.08 from the previous closing price of $1.33 on volume of 223,033 shares. Over the past year the S&P 500 has gained 15.08% while CARA has fallen -86.62%. CARA lost -$2.07 per share the …Where the stock market will trade today based on Dow Jones Industrial Average, S&P 500 and Nasdaq-100 futures and implied open premarket values. Commodities, currencies and global indexes also shown.Institutional Ownership and Shareholders. Cara Therapeutics Inc (US:CARA) has 284 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30,570,531 shares. Largest shareholders include BlackRock Inc., Vanguard Group Inc, Disciplined Growth ...Nov 13, 2023 · Cara Therapeutics Inc’s trailing 12-month revenue is $27.2 million with a -410.9% profit margin. Year-over-year quarterly sales growth most recently was -70.0%. Analysts expect adjusted earnings to reach $-1.998 per share for the current fiscal year. Cara Therapeutics Inc does not currently pay a dividend. The Trend in the Analyst Price Target. CARA's average price target has moved down $22.12 over the prior 42 months. Over the past 45 weeks, CARA's average upside potential has been 426.28%. Date.Find the latest analyst research for Cara Therapeutics, Inc. Common Stock (CARA) at Nasdaq.com.

Apr 29, 2021 · What happened. Shares of Cara Therapeutics ( CARA -5.11%) were crashing 43.9% lower as of 11:17 a.m. EDT on Thursday. The big drop came after the company announced results from its phase 2 study ... CARA Stock 12 Months Forecast. $14.10. (1230.19% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Cara Therapeutics in the last 3 months. The average price target is $14.10 with a high forecast of $25.00 and a low forecast of $3.50. The average price target represents a 1230.19% change from the last price of $1.06. Aug 24, 2021 · Get the latest Cara Therapeutics Inc. (CARA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Cara Therapeutics, Inc. (CARA) stock forecast and price target. Find the latest Cara Therapeutics, Inc. CARA analyst stock forecast, price target, and recommendation trends with in-depth analysis ...The firm currently boasts a market capitalization value of $187.83 million alongside a price-earnings ratio of -2.23 and beta of 0.87. Nonetheless, with exponential growth attainable through various regulatory approvals, the research-based biopharmaceutical company appears primed to deliver cutting-edge solutions that resonate in today’s ...Aug 11, 2021 · The PEG ratio is a company's P/E ratio divided by the annual earnings growth rate and is typically around 1 for a fairly valued company. Working backward from a PEG ratio of 1, I forecasted a $51 ...

Cara Therapeutics, Inc. (CARA) stock forecast and price target. Find the latest Cara Therapeutics, Inc. CARA analyst stock forecast, price target, and recommendation trends with in-depth analysis ...

Cara Therapeutics, Inc. (CARA) stock forecast and price target Find the latest Cara Therapeutics, Inc. CARA analyst stock forecast, price target, and recommendation trends with in-depth analysis ..."CARA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "CARA" projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Cara Therapeutics Inc.Cara Therapeutics Inc (CARA) stock is trading at $4.98 as of 3:31 PM on Thursday, Mar 23, a decline of -$0.20, or -3.86% from the previous closing price of $5.18. The stock has traded between $4.94 and $5.33 so far today. Volume today is below average. So far 419,735 shares have traded compared to average volume of 832,550 shares.What happened. Shares of Cara Therapeutics ( CARA 12.38%) had plunged 27.8% lower as of 10:54 a.m. EST on Tuesday. The big drop came after the drugmaker announced results from a phase 2 clinical ...What's Happening with CARA Stock Today. Cara Therapeutics Inc (CARA) stock is higher by 2.07% while the S&P 500 is higher by 1.41% as of 3:38 PM on Wednesday, Mar 29. CARA is higher by $0.10 from the previous closing price of $4.94 on volume of 309,020 shares. Over the past year the S&P 500 is down -13.05% while CARA …Nov 29, 2023 · The Cara Therapeutics stock price fell by -1.90% on the last day (Wednesday, 29th Nov 2023) from $0.98 to $0.96. During the last trading day the stock fluctuated 7.37% from a day low at $0.95 to a day high of $1.02. The price has fallen in 6 of the last 10 days and is down by -12.47% for this period. Volume has increased on the last day by 227 ... Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...

24 thg 11, 2023 ... Quant Rating History · Go Premium to see CARA Quant Rating · Navigate the Stock Market with Seeking Alpha.

Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), MoonLake Immunotherapeutics (MLTX) and Cara Therapeutics (CARA) November 14, 2023TipRanks. Cara shares ‘highly disconnected ...

Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...585.00. +10.63%. 14.84M. View the real-time Cara Therapeutic (NASDAQ CARA) share price and assess historical data, charts, technical analysis and the share chat forum.The current Cara Therapeutics [ CARA] share price is $1.09. The Score for CARA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. CARA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.The current Cara Therapeutics [ CARA] share price is $0.98. The Score for CARA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal. CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.Sebelum masuk ke tutorial cara tambah produk dan cara stock opname produk, mari simak terlebih dahulu mengenai apa itu Jurnal.id lebih dekat.. Apa itu Jurnal.id? Jurnal.id adalah software akuntansi online yang diproduksi oleh PT Mid Solusi Nusantara (Mekari). Software ini mendukung kegiatan pencatatan keuangan, pembukuan, dan …Cara Therapeutics' Q4 earnings EPS loss was $0.56 per share. Read why I am looking to quickly book some profits in CARA stock.Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.6 brokerages have issued 1-year price targets for Cara Therapeutics' stock. Their CARA share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $15.86 in the next twelve months. This suggests a possible upside of 1,396.0% from the stock's current price.Sebelum masuk ke tutorial cara tambah produk dan cara stock opname produk, mari simak terlebih dahulu mengenai apa itu Jurnal.id lebih dekat.. Apa itu Jurnal.id? Jurnal.id adalah software akuntansi online yang diproduksi oleh PT Mid Solusi Nusantara (Mekari). Software ini mendukung kegiatan pencatatan keuangan, pembukuan, dan …CARA and Weed heating up this could go anyway at the moment but strong volume and huge gap to fill on this chart but we have earnings coming out Monday after hours so could pump if beats or could act as a good price entry for long swing. Im holding calls for the move over 18.15 I want 20+. this could go anyway at the moment but strong volume and huge …

Nov 13, 2013 · A high-level overview of Cara Therapeutics, Inc. (CARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cara Therapeutics Inc’s trailing 12-month revenue is $27.2 million with a -410.9% profit margin. Year-over-year quarterly sales growth most recently was -70.0%. Analysts expect adjusted earnings to reach $-1.998 per share for the current fiscal year. Cara Therapeutics Inc does not currently pay a dividend.Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA).Instagram:https://instagram. arizona dental insurancewagergptdividend pay date calendarxtn stock Explore new charts. Discover historical prices for CARA stock on Yahoo Finance. View daily, weekly or monthly format back to when Cara Therapeutics, Inc. stock was issued. stonecosiyata Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.The Cara Therapeutics stock price fell by -1.90% on the last day (Wednesday, 29th Nov 2023) from $0.98 to $0.96. During the last trading day the stock fluctuated 7.37% from a day low at $0.95 to a day high of $1.02. The price has fallen in 6 of the last 10 days and is down by -12.47% for this period. Volume has increased on the last day by 227 ... managed trading accounts Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...13 thg 11, 2023 ... CARA Stock Data. Industry Pharmaceutical Preparation Manufacturing. Sector Manufacturing. Website Link. Tags Health Technology, Biotechnology ...